led to the myocardial infarction, and death. Pathological manifestation of cardiac involvement in PN included the left ventricular hypertrophy due to renovascular arterial hypertension in 26 cases (70.3%). In addition, interstitial myocarditis was observed in 4 cases (10.8%). Conclusions: Our date suggest that cardiac involvement is common in polyarteritis nodosa (81.1%), and coronary vasculitis affecting medium and small-sized arteries with wide range of acute and chronic changes can be the life-threatening condition.
led to the myocardial infarction, and death. Pathological manifestation of cardiac involvement in PN included the left ventricular hypertrophy due to renovascular arterial hypertension in 26 cases (70.3%). In addition, interstitial myocarditis was observed in 4 cases (10.8%). Conclusions: Our date suggest that cardiac involvement is common in polyarteritis nodosa (81.1%), and coronary vasculitis affecting medium and small-sized arteries with wide range of acute and chronic changes can be the life-threatening condition. Cutaneous PAN was more frequent in the UK group (12 pts vs. 4pts, p=0.031) whereas renal involvement was increased in the TR group (Table) . In contrast to systemic involvement, female predominance was seen in cutaneous PAN (40.3% vs. 68.8%, p=0.037). DEI was similar in both systemic involved groups (6.1 (2.4) vs. 6.5 (2.3), p=0.428). No difference was found between paediatric and adult onset patients except for frequency of cutaneous lesions (100% vs. 64.3%, p=0.002). During a median 67.5 (32-126) months follow up, 13 patients deceased. No difference was found between the groups regarding relapse rate, death and vasculitis damage index (Table) .
Conclusions: Even though, the Turkish group had a younger disease onset and higher additional monogenic disease; disease extent, relapse rate, death, and damage index were similar in both groups. Among the cutaneous PAN group there was a female predominance. A multi-centre GWAS study could highlight the impact of genetic background on disease presentation and severity. Disclosure of Interest: None declared DOI: 10.1136/annrheumdis-2017-eular.5074 Background: The association of chronic inflammatory rheumatic disorders with an increased risk of vascular disease, especially cardiovascular and cerebrovascular disease, is a consolidated matter, but data on polymyalgia rheumatica (PMR) are still inconsistent. Objectives: The aim of our cross-sectional study was to investigate the presence of vascular damage in patients with PMR by analyzing subclinical vascular disease through validated, non-invasive cardiovascular disease markers. Methods: We enrolled patients with PMR diagnosed according to the EULAR classification criteria and, as controls, patients with major cardiovascular risk factors (MCVRF) including hypertension, diabetes, hypercholesterolemia, cigarette smoking, and obesity. In all of them we performed color Doppler ultrasound to evaluate the common carotid intima-media thickness (IMT), the prevalence of carotid artery stenosis and of anterior-posterior abdominal aortic diameter (APAD); we also assessed the cardio-ankle vascular index (CAVI) to measure arterial stiffness and contextually the ankle-brachial index (ABI) to investigate the presence of lower-extremity peripheral arterial disease. 
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